Introduction Pentobarbital, often known by its trade name Nembutal, is a short-acting barbiturate that continues to generate complex legal, ethical, and medical discussions across Europe. In 2025, the conversation around its legality in Spain, use in assisted dying in Switzerland, and prescribing guidelines in the UK remains highly relevant to both healthcare professionals and the […]